The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 05, 2017
Filed:
Sep. 12, 2016
Applicant:
Olatec Therapeutics Llc, New York, NY (US);
Inventors:
Joseph P. St. Laurent, Lakeville, MA (US);
Gerald S. Jones, Norwood, MA (US);
David M. Bresse, Middleboro, MA (US);
Scott A. Goodrich, Stoughton, MA (US);
Assignee:
Olatec Therapeutics LLC, New York, NY (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/277 (2006.01); C07C 315/02 (2006.01); C07C 317/28 (2006.01); C07C 317/44 (2006.01); C07C 319/12 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/277 (2013.01); A61K 9/0014 (2013.01); A61K 9/0053 (2013.01); C07C 315/02 (2013.01); C07C 317/28 (2013.01); C07C 317/44 (2013.01); C07C 319/12 (2013.01);
Abstract
The present invention is directed to a method of treating inflammation or pain. The present invention is also directed to a method of treating an inflammatory skin disease or disorder, such as dermatitis, psoriasis, acne, or rosacea. The method comprises administering to the subject 3, 4-bis-benzylsulfonylbutyronitrile in an amount effective to reduce or eliminate the symptoms of the disease or disorder. Topical administration and oral administration are preferred route of administration.